FDA Orange Book · active-ingredient family
Fenofibric acid
Fenofibric acid is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:FIBRICOR · NDA 022418
1
Brand (NDA)
0
Generics (ANDA)
4
Listed patents
0
Exclusivity periods
Brand (NDA) products · tablet
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| FIBRICORRLD×2 | ROSEMONT | NDA 022418 | — | Aug 14, 2009 |
Listed patents (4)
| Patent | Expires | In | Type |
|---|---|---|---|
| 7569612 | Aug 20, 2027 | in 1 yr 2 mo | U-1000 |
| 7741374 | Aug 20, 2027 | in 1 yr 2 mo | U-1061 |
| 7741373 | Aug 20, 2027 | in 1 yr 2 mo | U-1059 |
| 7915247 | Aug 20, 2027 | in 1 yr 2 mo | U-1061 |
Fenofibric acid — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
